CLINICAL_TRIALS
trial_result
· 2016-02-10
Clinical Trial Update: Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly [Phase 2]
Summary
A Phase 2 clinical trial evaluating repeated administration of BIM 23A760 in acromegaly was terminated with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Acromegaly | Phase 2 | Status: TERMINATED | Results posted: 2016-02-10